Overview
Pharmaceuticals and Healthcare
Comprehensive advice and representation
We regularly advise our clients in the pharmaceutical, medical device, biotechnology, life sciences, chemistry, foodstuffs and cosmetics sector on their day-to-day business, for example in research and development (particularly in clinical trials), intellectual property enforcement, regulatory authorizations, advertising and distribution issues, pricing strategies and reimbursements under social security law as well as all regulatory issues (compliance) and data protection.
We support our healthcare clients (service providers such as hospitals, HMOs, nursing homes, laboratories, physicians, pharmacists, etc.) in particular in the areas of social security regulatory authorisations, professional law, data protection, tariff negotiations and tariff settings, planning (hospital planning, planning of highly-specialised medicine), liability issues and compliance.
Whether you require professional support in the area of contracts, strategic agreements, in competition and antitrust or tax law, or an expert opinion, are planning a corporate transaction or seek to engage in legal proceedings or are affected by legal, administrative or criminal proceedings, we are delighted to assist you.
Contact Partner: Felix Kesselring
Our team for Pharmaceuticals and Healthcare
To the team
Know-how on Pharmaceuticals and Healthcare
Publication
Schulthess Forum Medizinprodukterecht 2021 - Die Umsetzung der Revision
Learn more
Publication
Berner Tagung zum Life Science Recht - Datenschutz im Gesundheitswesen
Learn more
Presentation
Zwischen Regelung und Rätsel: Entschlüsselung der Neuregelung der Einzelfallvergütung (Art. 71a ff. KVV und Art. 38b ff. KLV)
Learn moreNews on Pharmaceuticals and Healthcare
07.05.2025
Learn more
Voyager Acquisition Corp. and Veraxa Biotech AG Announce Business Combination
Bratschi represented Voyager Acquisition Corp., a publicly traded Cayman Islands Special Purpose Acquisition Company (SPAC), on Swiss law related aspects concerning its announced business combination agreement with Zurich-based Veraxa Biotech AG, a biopharmaceutical company developing next-generation antibody-based cancer therapies.
21.03.2025
Learn more
Chambers Europe Guide 2025
We are pleased to inform you that Bratschi AG has been recognized in the prestigious Chambers Europe 2025 edition.
21.03.2024
Learn more
Chambers Europe Rankings 2024
We are pleased to announce that Bratschi AG has been recognized in the 2024 edition of the prestigious international Chambers Europe.